Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus.
about
Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria.Gut Microbiome and Kidney Disease in Pediatrics: Does Connection Exist?Phenylketonuria: a review of current and future treatmentsThe Gut as a Source of Inflammation in Chronic Kidney DiseaseRole of the Gut Microbiome in Uremia: A Potential Therapeutic Target.Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patientsGut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney diseaseThe gut microbiome, kidney disease, and targeted interventions.Effects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiotaEffect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial.Exploring the Microbiome in Heart FailureProbiotics, prebiotics, and synbiotics: gut and beyondCancer prevention as biomodulation: targeting the initiating stimulus and secondary adaptationsGut Microbiota in Cardiovascular Health and Disease.Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.L-Carnitine improves gastrointestinal disorders and altered the intestinal microbiota in hemodialysis patients.Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy.The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal DisordersInflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and OutcomeGut Microbiota and Cardiovascular Uremic Toxicities
P2860
Q24806569-B22D0364-C43C-4F7E-8E04-9523240F69F9Q26765943-BF24C748-B8DE-4AD7-AC5F-80C2E7F6BA0EQ26770291-194339F6-B3B5-4067-96E5-04CAF751BB60Q28081781-FD63B2D0-E257-40EA-9A11-6277D6B42C04Q33613115-6080936B-6999-429F-A42E-0A0DD70F2AC3Q34043268-2C9B8324-D8AE-40CF-ACFA-C6E3CD592953Q35033613-EDE34409-FB4A-4842-874C-4DE1D1D7F8EDQ35042986-D83942C5-5A84-4D6A-A679-49EB684F64E7Q35327301-D763588C-1200-4412-9460-B5D7701770A2Q35865699-341BD203-0973-4EAE-AEEC-BEE53D89D27BQ35926145-86F99871-72DB-48DE-A73A-4DEFBEA3C517Q36282616-F0E35D31-93AA-450A-AEE7-8CBD82C6FC46Q36317659-2573C0B9-81A7-4CAE-81E1-76F849822942Q36329055-5E98917B-3EAF-4442-A1C5-BDC036BF48DCQ36666953-A6C56AF7-B732-4614-9656-64026B696BF9Q37357860-A85B61DB-B1AB-48C8-A371-CD54CC46DEC0Q37634779-F49C1BC9-91C8-4C6D-BEB7-9796665469C2Q40518328-3454D53B-1FCD-43B5-800B-A0C80145F630Q47165669-71DFB84A-53C4-4BE6-B1EF-14236AAA5055Q57072601-D104FCD3-E838-4CED-812D-D6BCB1E1E31BQ57117487-F1A69048-EA3E-485C-B96E-3DDDBF940227Q57176511-F1C72460-AC81-40B9-9D49-C196AA93F369
P2860
Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Biomodulation of the toxic and ...... ied Lactobacillus acidophilus.
@en
Biomodulation of the toxic and ...... ied Lactobacillus acidophilus.
@nl
type
label
Biomodulation of the toxic and ...... ied Lactobacillus acidophilus.
@en
Biomodulation of the toxic and ...... ied Lactobacillus acidophilus.
@nl
prefLabel
Biomodulation of the toxic and ...... ied Lactobacillus acidophilus.
@en
Biomodulation of the toxic and ...... ied Lactobacillus acidophilus.
@nl
P2093
P1476
Biomodulation of the toxic and ...... ried Lactobacillus acidophilus
@en
P2093
Fitzpatrick ME
Sandine WE
Simenhoff ML
Zollner GP
P577
1996-01-01T00:00:00Z